| 发明名称 |
Treatment of obesity and essential hypertension and related disorders |
| 摘要 |
The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.
|
| 申请公布号 |
US5364841(A) |
申请公布日期 |
1994.11.15 |
| 申请号 |
US19930081033 |
申请日期 |
1993.06.21 |
| 申请人 |
AMYLIN PHARMACEUTICALS, INC. |
发明人 |
COOPER, GARTH J. S.;LEIGHTON, BRENDAN |
| 分类号 |
A61K38/00;A61K38/22;C07K14/575;C07K16/26;(IPC1-7):C07K7/06;C07K7/08;C07K7/10;A61K37/02 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
